Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Z
Zanghi, James
Genentech, Inc.
(
T1230-02-09
)
Population Pharmacokinetics and Exposure-Efficacy and -Safety Analyses of Atezolizumab for Subcutaneous Injection in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer
James Zanghi
Favorite
Zanghi, Jim
Genentech, Inc.
(
T1430-01-03
)
Val-His-Ser (VHS) N-terminal Leader Sequence and Implications for mAb Subcutaneous Pharmacokinetics
Jim Zanghi
Favorite
Zepeda, Guadalupe
NeuroOne
(
W1430-01-04
)
Innovative Device for Concomitant Therapeutic Compound Delivery into the Brain and Neural Recordings - Feasibility Bench and In Vivo Studies
Guadalupe Zepeda
Favorite
Zhang, Pingping
Cellentia, Inc.
(
T1330-02-10
)
Novel Immunoassay Technology: Evaluating the PIXI Platform for Rapid Quantitation with Automation, Wide Dynamic Range, and Small Sample Volume Requirement
Pingping Zhang
Favorite
(
W1430-02-08
)
In Vitro Method Using Circulating Tumor Cells-Derived Organoids from Patients with Solid Tumors to Transform Oncology Drug Development
Pingping Zhang
Favorite
Zhang, Ruobo
Cellentia, Inc.
(
W1430-02-08
)
In Vitro Method Using Circulating Tumor Cells-Derived Organoids from Patients with Solid Tumors to Transform Oncology Drug Development
Ruobo Zhang
Favorite
Zhao, Harry
Frontage Laboratories, Inc.
(
W1530-02-11
)
Evaluation of API 7500 Integrated System with Microflow LC System M5 Using Sulfamethazine (SDX) Neat Solution
Harry Zhao
Favorite
Zhao, Song
Frontage Laboratories, Inc.
(
W1530-02-11
)
Evaluation of API 7500 Integrated System with Microflow LC System M5 Using Sulfamethazine (SDX) Neat Solution
Song Zhao
Favorite
Zhao, Wanbing
AliveX Biotech
(
T1030-02-06
)
A Mechanistic Model of IgG4-RD Identifies High-Potential Therapy Targets
Wanbing Zhao
Favorite
Zhong, Yu
Genentech, Inc.
(
T1130-02-07
)
Anti-CCR8 Mediated Depletion of Tumor-Infiltrating Regulatory T Cells: Preclinical PK/PD and Translational Strategy in Support of Clinical Development for Solid Tumor Indications
Yu Zhong
Favorite
